Nonclinical & Early Development Services
Optimize early drug development studies and decisions with our partner labs for First-in-Rodent®, in vitro ADME assays, and Model Informed Drug Development. We partner with our clients to help with candidate selection, dose prediction PK/PD, and Pre-IND readiness and transitions to early clinical development. make the description brief
Key Features:
Patient Integration Experience (PIE)
Capture patient insights early to inform trial design, improve feasibility, and increase engagement.
Real-World Evidence (RWE)
Leverage robust evidence from real-world settings to support clinical and commercial decision-making.
Real-World Data (RWD) Insights
Utilize real-time data from EHRs, claims, and registries to optimize site selection, protocol adjustments, and regulatory submissions.
Accelerated Trial Enrollment
Enhance recruitment strategies with data-driven patient targeting and tailored outreach.
Differentiated Evidence Packages
Deliver unmatched support for go/no-go decisions using integrated PIE, RWD, and RWE to reduce risk and drive success.
